Stockreport

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis

Reviva Pharmaceuticals Holdings, Inc.  (RVPH) 
PDF - Patent covers brilaroxazine use for treating Pulmonary Fibrosis -Similar patents have also been granted in key markets around the world including the United States, C [Read more]